A Novel Cognitive Stress Test for the Detection of Preclinical Alzheimer Disease: Discriminative Properties and Relation to Amyloid Load
- PMID: 27160985
- PMCID: PMC5026876
- DOI: 10.1016/j.jagp.2016.02.056
A Novel Cognitive Stress Test for the Detection of Preclinical Alzheimer Disease: Discriminative Properties and Relation to Amyloid Load
Abstract
Objective: To examine the utility of a novel "cognitive stress test" to detect subtle cognitive impairments and amyloid load within the brains of neuropsychologically normal community-dwelling elders.
Methods: Participants diagnosed as cognitively normal (CN), subjective memory impairment (SMI), mild cognitive impairment (MCI), and preclinical mild cognitive impairment (PreMCI) were administered the Loewenstein-Acevedo Scale for Semantic Interference and Learning (LASSI-L), a sensitive test of proactive semantic interference (PSI), retroactive semantic interference, and, uniquely, the ability to recover from the effects of PSI. Ninety-three subjects (31 men and 62 women) were recruited from three academic institutions in a research consortium. A subset of these individuals underwent 18F florbetapir positron emission tomography scanning. Relative percentages of impairment for each diagnostic group on the LASSI-L were calculated by χ(2) and Fisher's exact tests. Spearman's rho was used to examine associations between amyloid load and different cognitive measures.
Results: LASSI-L deficits were identified among 89% of those with MCI, 47% with PreMCI, 33% with SMI, and 13% classified as CN. CN subjects had no difficulties with recovery from PSI, whereas SMI, preMCI, and MCI participants evidenced deficits in recovery from PSI effects. Among a subgroup of participants with normal scores on traditional neuropsychological tests, the strong associations were between the failure to recover from the effects of PSI and amyloid load in the brain.
Conclusion: Failure to recover or compensate for the effects of PSI on the LASSI-L distinguishes the LASSI-L from other widely used neuropsychological tests and appears to be sensitive to subtle cognitive impairments and increasing amyloid load.
Keywords: LASSI-L; MCI; PreMCI; amyloid; proactive interference recovery.
Copyright © 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.
Comment in
-
Sensitive and Specific Preclinical Identification of Alzheimer Disease: A Key to Novel Intervention Development.Am J Geriatr Psychiatry. 2016 Oct;24(10):814-5. doi: 10.1016/j.jagp.2016.07.010. Epub 2016 Aug 4. Am J Geriatr Psychiatry. 2016. PMID: 27600364 Free PMC article. No abstract available.
References
-
- Rentz DM, Parra Rodriguez MA, Amariglio R, Stern Y, Sperling R, Ferris S. Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review. Alzheimers Res Ther. Nov 21. 2013;5(6):58. http://www.alzres.com/content/5/6/58. - PMC - PubMed
-
- Sperling R, Aisen P, Beckett L, Bennett DA, Craft, et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia. 2011;7(3):280–292. - PMC - PubMed
-
- Papp K, Rentz D, Mormino E, Amariglio R, Burnham S, Johnson K, Sperling R. The neuropsychology of preclinical Alzheimer's disease: Differential sensitivity of component processes of memory performance on biomarker evidence of amyloidosis. Neuropsychologia. 2015;73:69–175.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
